Literature DB >> 21517744

Recent patents on the synthesis and application of silica nanoparticles for drug delivery.

Maria Lucia Foglia1, Gisela Solange Alvarez, Paolo Nicolás Catalano, Andrea Mathilde Mebert, Luís Eduardo Diaz, Thibaud Coradin, Martín Federico Desimone.   

Abstract

Drug delivery systems are designed to improve therapy efficacy as well as patient compliance. This could be accomplished by specifically targeting a medication intact to its active site, therefore reducing side-effects and enabling high local drug concentrations. Silica nanoparticles have gained ground in the biomedical field for their biocompatibility and biodegradability, being themselves inert and stable, thus enabling a variety of formulation designs for application in the pharmaceutical industry. This paper is a review of the recent patents on the applications of silica nanoparticles for drug delivery and their preparation. The review will focus on the different techniques available to obtain silica nanoparticles with variable morphology and their drug targeting applications, providing an overview of silica particles synthesis described in the literature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517744     DOI: 10.2174/187220811795655887

Source DB:  PubMed          Journal:  Recent Pat Biotechnol        ISSN: 1872-2083


  3 in total

1.  Photo-triggerable Hydrogel-Nanoparticle Hybrid Scaffolds for Remotely Controlled Drug Delivery.

Authors:  Shreyas Shah; Pijus K Sasmal; Ki-Bum Lee
Journal:  J Mater Chem B       Date:  2014       Impact factor: 6.331

Review 2.  Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines.

Authors:  Romina Mitarotonda; Exequiel Giorgi; Tatiane Eufrasio-da-Silva; Alireza Dolatshahi-Pirouz; Yogendra Kumar Mishra; Ali Khademhosseini; Martin F Desimone; Mauricio De Marzi; Gorka Orive
Journal:  Biomater Adv       Date:  2022-04-22

Review 3.  Sol-gel Silica Nanoparticles in Medicine: A Natural Choice. Design, Synthesis and Products.

Authors:  M Clara Gonçalves
Journal:  Molecules       Date:  2018-08-13       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.